Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G H Sands

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Alimentary Pharmacology & Therapeutics|July 19, 2012
Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR)A Lanas, J L Goldstein, F K L Chan, et al.
Alimentary Pharmacology & Therapeutics|August 4, 2011
Haemoglobin decreases in NSAID users over time: an analysis of two large outcome trialsJ L Goldstein, F K L Chan, A Lanas, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Alimentary Pharmacology & Therapeutics|July 19, 2012
Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR)A Lanas, J L Goldstein, F K L Chan, et al.
Alimentary Pharmacology & Therapeutics|August 4, 2011
Haemoglobin decreases in NSAID users over time: an analysis of two large outcome trialsJ L Goldstein, F K L Chan, A Lanas, et al.
Pageof 2